PFE | Pfizer Inc.

AstraZeneca confuses investors after reporting two different efficacy rates achieved by its Covid-19 vaccine
AstraZeneca will sell its vaccine to governments at significantly lower prices as compared to Pfizer and Moderna.
By Staff | 1 month ago

Pfizer Inc. initiates Covid-19 vaccine shipment trial
The company has selected Texas, New Mexico, Tennessee, and Rhode Island for the pilot program
By Staff | 1 month ago
PFE

Moderna Inc. (MRNA) says its Covid-19 vaccine more than 94 percent effective in Phase-III trials
Pfizer shares fell nearly 3 percent in the pre-market trading Monday following Moderna’s announcement.
By Staff | 2 months ago

Pfizer has a potential vaccine. Now what?
Industries like entertainment, travel and hospitality, airlines, cruise ships, and casinos, were just a few of the sectors that reacted positively to the news.
By Mike Sakuraba | 2 months ago
PFE

Pfizer Inc. (PFE) shares hit new 52-week high after positive results of Covid-19 vaccine
Pfizer says its experimental coronavirus vaccine more than 90 percent effective in trials
By Staff | 2 months ago

The COVID-19 vaccine market will not be a winner-takes-all
The US government has selected three vaccine candidates to fund their Phase 3 trials through Operation Warp Speed.
By Alcides | 5 months ago

Pfizer and BioNTech Granted FDA Fast Track Designation for COVID-19 vaccines
Pfizer and BioNTech were granted fast track designation by the FDA for two of the companies’ four vaccine candidates against the coronavirus.
By Staff | 6 months ago

Pfizer Pledges $100 Million to Fight Growing Threat of Antimicrobial Resistance
New Partnership with More than 20 Other Companies Will Focus on Medicines that Address Most Resistant Bacteria and Life-Threatening Infections
By Staff | 6 months ago
PFE